Global Antimicrobials for Pets Market Research Report 2024

Publication ID:

PB507247813

Publication Date:

July 3, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
The global Antimicrobials for Pets market was valued at US$ 1152 million in 2023 and is anticipated to reach US$ 1723.5 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 49%.
This report aims to provide a comprehensive presentation of the global market for Antimicrobials for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobials for Pets.
Report Scope
The Antimicrobials for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimicrobials for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobials for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Segment by Type
Powder
Liquid
Segment by Application
Cat
Dog
Reptile
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antimicrobials for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antimicrobials for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Antimicrobials for Pets Market Overview
1.1 Product Overview and Scope of Antimicrobials for Pets
1.2 Antimicrobials for Pets Segment by Type
1.2.1 Global Antimicrobials for Pets Market Value Comparison by Type (2024-2030)
1.2.2 Powder
1.2.3 Liquid
1.3 Antimicrobials for Pets Segment by Application
1.3.1 Global Antimicrobials for Pets Market Value by Application: (2024-2030)
1.3.2 Cat
1.3.3 Dog
1.3.4 Reptile
1.3.5 Other
1.4 Global Antimicrobials for Pets Market Size Estimates and Forecasts
1.4.1 Global Antimicrobials for Pets Revenue 2019-2030
1.4.2 Global Antimicrobials for Pets Sales 2019-2030
1.4.3 Global Antimicrobials for Pets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antimicrobials for Pets Market Competition by Manufacturers
2.1 Global Antimicrobials for Pets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antimicrobials for Pets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antimicrobials for Pets Average Price by Manufacturers (2019-2024)
2.4 Global Antimicrobials for Pets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antimicrobials for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antimicrobials for Pets, Product Type & Application
2.7 Antimicrobials for Pets Market Competitive Situation and Trends
2.7.1 Antimicrobials for Pets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antimicrobials for Pets Players Market Share by Revenue
2.7.3 Global Antimicrobials for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antimicrobials for Pets Retrospective Market Scenario by Region
3.1 Global Antimicrobials for Pets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antimicrobials for Pets Global Antimicrobials for Pets Sales by Region: 2019-2030
3.2.1 Global Antimicrobials for Pets Sales by Region: 2019-2024
3.2.2 Global Antimicrobials for Pets Sales by Region: 2025-2030
3.3 Global Antimicrobials for Pets Global Antimicrobials for Pets Revenue by Region: 2019-2030
3.3.1 Global Antimicrobials for Pets Revenue by Region: 2019-2024
3.3.2 Global Antimicrobials for Pets Revenue by Region: 2025-2030
3.4 North America Antimicrobials for Pets Market Facts & Figures by Country
3.4.1 North America Antimicrobials for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antimicrobials for Pets Sales by Country (2019-2030)
3.4.3 North America Antimicrobials for Pets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antimicrobials for Pets Market Facts & Figures by Country
3.5.1 Europe Antimicrobials for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antimicrobials for Pets Sales by Country (2019-2030)
3.5.3 Europe Antimicrobials for Pets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antimicrobials for Pets Market Facts & Figures by Country
3.6.1 Asia Pacific Antimicrobials for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antimicrobials for Pets Sales by Country (2019-2030)
3.6.3 Asia Pacific Antimicrobials for Pets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antimicrobials for Pets Market Facts & Figures by Country
3.7.1 Latin America Antimicrobials for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antimicrobials for Pets Sales by Country (2019-2030)
3.7.3 Latin America Antimicrobials for Pets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antimicrobials for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Antimicrobials for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antimicrobials for Pets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antimicrobials for Pets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antimicrobials for Pets Sales by Type (2019-2030)
4.1.1 Global Antimicrobials for Pets Sales by Type (2019-2024)
4.1.2 Global Antimicrobials for Pets Sales by Type (2025-2030)
4.1.3 Global Antimicrobials for Pets Sales Market Share by Type (2019-2030)
4.2 Global Antimicrobials for Pets Revenue by Type (2019-2030)
4.2.1 Global Antimicrobials for Pets Revenue by Type (2019-2024)
4.2.2 Global Antimicrobials for Pets Revenue by Type (2025-2030)
4.2.3 Global Antimicrobials for Pets Revenue Market Share by Type (2019-2030)
4.3 Global Antimicrobials for Pets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antimicrobials for Pets Sales by Application (2019-2030)
5.1.1 Global Antimicrobials for Pets Sales by Application (2019-2024)
5.1.2 Global Antimicrobials for Pets Sales by Application (2025-2030)
5.1.3 Global Antimicrobials for Pets Sales Market Share by Application (2019-2030)
5.2 Global Antimicrobials for Pets Revenue by Application (2019-2030)
5.2.1 Global Antimicrobials for Pets Revenue by Application (2019-2024)
5.2.2 Global Antimicrobials for Pets Revenue by Application (2025-2030)
5.2.3 Global Antimicrobials for Pets Revenue Market Share by Application (2019-2030)
5.3 Global Antimicrobials for Pets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Antimicrobials for Pets Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Antimicrobials for Pets Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Antimicrobials for Pets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Antimicrobials for Pets Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Antimicrobials for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dechra Veterinary Products Antimicrobials for Pets Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Antimicrobials for Pets Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Antimicrobials for Pets Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Corporation Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ouro Fino Saude Antimicrobials for Pets Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Corporation Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Norbrook Antimicrobials for Pets Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Corporation Information
6.11.2 Jindun Antimicrobials for Pets Description and Business Overview
6.11.3 Jindun Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jindun Antimicrobials for Pets Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Wuhan chopperlvya
6.12.1 Wuhan chopperlvya Corporation Information
6.12.2 Wuhan chopperlvya Antimicrobials for Pets Description and Business Overview
6.12.3 Wuhan chopperlvya Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wuhan chopperlvya Antimicrobials for Pets Product Portfolio
6.12.5 Wuhan chopperlvya Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Antimicrobials for Pets Description and Business Overview
6.13.3 CAHIC Antimicrobials for Pets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAHIC Antimicrobials for Pets Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antimicrobials for Pets Industry Chain Analysis
7.2 Antimicrobials for Pets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antimicrobials for Pets Production Mode & Process
7.4 Antimicrobials for Pets Sales and Marketing
7.4.1 Antimicrobials for Pets Sales Channels
7.4.2 Antimicrobials for Pets Distributors
7.5 Antimicrobials for Pets Customers
8 Antimicrobials for Pets Market Dynamics
8.1 Antimicrobials for Pets Industry Trends
8.2 Antimicrobials for Pets Market Drivers
8.3 Antimicrobials for Pets Market Challenges
8.4 Antimicrobials for Pets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂